Objective: To compare the success rates and efficiency of ureterolithotripsy (URL) and extracorporeal shock wave lithotripsy (SWL) for proximal ureteric stones. Casuistry and Methods: A prospective non-randomized study was performed between 1999 and 2004. Of a total of 235 patients, 121 underwent SWL and 114 had ureteroscopy with ultrasonic lithotripsy. There were no significant differences between the groups. The success rate, operative time, postoperative pain and complications were analyzed in each group. Patients were followed postoperatively for a minimum of 3 months (median 6 months).Results: Treatment success rate was defined as the complete removal or as the radiographic absence of calculi at a 3-month follow-up. The URL success rate was 85.6% (98/114) and 89.5% (68/95) after one SWL session and (77/85) 90.6% after a second treatment. No differences were found in the results, overall complication rates and mean procedure time. However, the fluoroscopy time was longer in the URL group and pain was more frequent. Conclusions: Semirigid URL is as efficient as SWL in the treatment for proximal ureteral stone. However, SWL requires less fluoroscopic time and fewer pain relievers.

This content is only available via PDF.
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.